Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tenon Medical (TNON) Cash from Investing Activities (2021 - 2025)

Historic Cash from Investing Activities for Tenon Medical (TNON) over the last 5 years, with Q3 2025 value amounting to -$639000.0.

  • Tenon Medical's Cash from Investing Activities fell 51442.31% to -$639000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$706000.0, marking a year-over-year decrease of 12412.7%. This contributed to the annual value of -$186000.0 for FY2024, which is 10302.83% down from last year.
  • Latest data reveals that Tenon Medical reported Cash from Investing Activities of -$639000.0 as of Q3 2025, which was down 51442.31% from $37000.0 recorded in Q4 2024.
  • Tenon Medical's 5-year Cash from Investing Activities high stood at $4.7 million for Q1 2023, and its period low was -$8.2 million during Q2 2022.
  • Its 5-year average for Cash from Investing Activities is -$147928.6, with a median of -$27500.0 in 2023.
  • As far as peak fluctuations go, Tenon Medical's Cash from Investing Activities soared by 14021.74% in 2024, and later tumbled by 51442.31% in 2025.
  • Quarter analysis of 5 years shows Tenon Medical's Cash from Investing Activities stood at $3.4 million in 2021, then crashed by 30.7% to $2.3 million in 2022, then crashed by 103.93% to -$92000.0 in 2023, then surged by 140.22% to $37000.0 in 2024, then plummeted by 1827.03% to -$639000.0 in 2025.
  • Its Cash from Investing Activities stands at -$639000.0 for Q3 2025, versus $37000.0 for Q4 2024 and -$104000.0 for Q3 2024.